BioCardia (BCDA) Earnings Date, Estimates & Call Transcripts $1.93 -0.07 (-3.50%) Closing price 04/10/2025 04:00 PM EasternExtended Trading$1.93 0.00 (0.00%) As of 04/10/2025 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioCardia Earnings Summary Upcoming Earnings DateMay. 13After Market ClosesEstimatedConsensus EPS (Mar. 26) -$0.87 Actual EPS (Mar. 26) -$0.25 Beat By $0.62 Actual Revenue (Mar. 26) $0.02MBioCardia posted Q4 2024 earnings on March 26, 2025, reporting an EPS of -$0.25, which topped analysts' consensus estimates of -$0.87 by $0.62. Quarterly revenue was reported to be $0.02 million, below the consensus estimate of $0.02 million. With a trailing EPS of -$3.09, BioCardia's earnings are expected to grow next year, from ($3.52) to ($1.22) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Annual Report (10-K) Press Release (8-K)BCDA Upcoming EarningsBioCardia's next earnings date is estimated for Tuesday, May 13, 2025, based on past reporting schedules. Powered by Get BioCardia Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioCardia and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBCDA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BCDA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads BioCardia Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($3.52) EPSNext Year EPS Consensus Estimate ($1.22) EPS Remove Ads BioCardia Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/13/2025(Estimated)--------3/26/2025Q4 2024-$0.87-$0.25+$0.62-$0.25$0.02M$0.02M8/13/2024Q2 2024-$0.10-$0.88 -$0.78-$0.88--5/14/2024Q1 2024--$1.35 -$1.35-$0.09-$0.06M3/27/2024Q4 2023-$1.65-$1.35+$0.30-$0.09$0.20M$0.01M11/8/2023Q3 2023-$1.80-$1.80--$0.12$0.05M$0.36M8/9/2023Q2 2023-$2.25-$2.55 -$0.30-$0.17$0.34M$0.04M5/10/2023Q1 2023-$1.95-$2.55 -$0.60-$0.17$0.34M$0.06M BioCardia Earnings - Frequently Asked Questions When is BioCardia's earnings date? BioCardia has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on BCDA's earnings history. Did BioCardia beat their earnings estimates last quarter? In the previous quarter, BioCardia (NASDAQ:BCDA) reported ($0.25) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.87) by $0.62. Learn more on analysts' earnings estimate vs. BCDA's actual earnings. How can I listen to BioCardia's earnings conference call? The conference call for BioCardia's latest earnings report can be listened to online. Listen to Conference Call How can I read BioCardia's conference call transcript? The conference call transcript for BioCardia's latest earnings report can be read online. Read Transcript How much revenue does BioCardia generate each year? BioCardia (NASDAQ:BCDA) has a recorded annual revenue of $58,000.00. How much profit does BioCardia generate each year? BioCardia (NASDAQ:BCDA) has a recorded net income of -$11.57 million. BCDA has generated -$3.09 earnings per share over the last four quarters. What is BioCardia's EPS forecast for next year? BioCardia's earnings are expected to grow from ($3.52) per share to ($1.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies Oncolytics Biotech Earnings Date bluebird bio Earnings Date Aadi Bioscience Earnings Date Immix Biopharma Earnings Date PepGen Earnings Date PDS Biotechnology Earnings Date Shattuck Labs Earnings Date Medicus Pharma Earnings Date Werewolf Therapeutics Earnings Date AlloVir Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:BCDA) was last updated on 4/11/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.